Business Description
Oruka Therapeutics is a clinical-stage medicine company based in Menlo Park, California, working to develop new antibody-based treatments for psoriasis and related inflammatory conditions. Its two lead treatments, ORKA-001 and ORKA-002, are currently in mid-stage clinical trials targeting different proteins involved in driving inflammation. The company is also exploring additional treatment approaches, including a combined therapy that uses both lead drugs in sequence.
